PortfoliosLab logo

ALX Oncology Holdings Inc. (ALXO)

Equity · Currency in USD · Last updated Sep 23, 2022

Company Info

ISINUS00166B1052
CUSIP00166B105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$10.54
Year Range$5.89 - $76.87
EMA (50)$12.05
EMA (200)$21.51
Average Volume$205.07K
Market Capitalization$454.74M

ALXOShare Price Chart


Chart placeholderClick Calculate to get results

ALXOPerformance

The chart shows the growth of $10,000 invested in ALX Oncology Holdings Inc. in Jul 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,527 for a total return of roughly -64.73%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-41.05%
-17.28%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

ALXOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-21.10%-9.18%
6M-42.93%-15.67%
YTD-50.77%-21.15%
1Y-86.08%-13.69%
5Y-37.97%7.26%
10Y-37.97%7.26%

ALXOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-25.55%13.25%-6.73%-24.38%-39.98%5.48%19.65%34.30%-18.62%
2021-8.06%1.31%-8.16%-15.03%-9.74%-3.32%7.10%19.54%5.51%-24.13%-42.61%-33.18%
20209.00%23.67%-6.68%4.69%94.71%12.05%

ALXOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current ALX Oncology Holdings Inc. Sharpe ratio is -1.00. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-1.00
-0.67
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

ALXODividend History


ALX Oncology Holdings Inc. doesn't pay dividends

ALXODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-90.58%
-21.65%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)

ALXOWorst Drawdowns

The table below shows the maximum drawdowns of the ALX Oncology Holdings Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the ALX Oncology Holdings Inc. is 94.75%, recorded on Jun 16, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-94.75%Dec 11, 2020381Jun 16, 2022
-27.58%Aug 18, 202032Oct 1, 202028Nov 10, 202060
-17.51%Nov 24, 20202Nov 25, 202010Dec 10, 202012
-7.17%Aug 10, 20202Aug 11, 20203Aug 14, 20205
-4.58%Jul 22, 20201Jul 22, 20204Jul 28, 20205
-2.91%Jul 29, 20201Jul 29, 20202Jul 31, 20203
-1.99%Nov 13, 20201Nov 13, 20201Nov 16, 20202
-1.65%Nov 18, 20201Nov 18, 20201Nov 19, 20202

ALXOVolatility Chart

Current ALX Oncology Holdings Inc. volatility is 57.18%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%AprilMayJuneJulyAugustSeptember
57.18%
25.76%
ALXO (ALX Oncology Holdings Inc.)
Benchmark (^GSPC)